<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.ivybraintumorcenter.org/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/</loc>
		<lastmod>2023-04-17T22:12:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/quantitative-and-mechanistic-understanding-of-azd1775-penetration-across-human-blood-brain-barrier-in-glioblastoma-patients-using-an-ivive-pbpk-modeling-approach/</loc>
		<lastmod>2019-10-29T17:46:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/phase-0-trial-of-azd1775-in-first-recurrence-glioblastoma-patients/</loc>
		<lastmod>2019-11-11T17:19:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/a-phase-0-trial-of-ribociclib-in-recurrent-glioblastoma-patients-incorporating-a-tumor-pharmacodynamic-and-pharmacokinetic-guided-expansion-cohort/</loc>
		<lastmod>2019-11-11T17:20:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/phase-0-clinical-trial-strategies-for-the-neurosurgical-oncologist/</loc>
		<lastmod>2020-03-11T14:10:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/a-liquid-chromatography-with-tandem-mass-spectrometry-method-for-quantitating-total-and-unbound-ceritinib-in-patient-plasma-and-brain-tumor/</loc>
		<lastmod>2020-03-11T16:45:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/nonredundant-isoform-specific-roles-of-hdac1-in-glioma-stem-cells/</loc>
		<lastmod>2021-10-01T17:53:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/5-aminolevulinic-acid-sonodynamic-therapy-in-recurrent-glioblastoma-a-first-in-human-phase-0-1-clinical-trial/</loc>
		<lastmod>2021-10-01T17:54:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/a-phase-0-1-trigger-trial-of-ribociclib-plus-everolimus-in-recurrent-high-grade-glioma/</loc>
		<lastmod>2021-10-01T17:55:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/nonredundant-isoform-specific-roles-of-hdac1-in-glioma-stem-cells-2/</loc>
		<lastmod>2022-06-02T20:38:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/simultaneous-determination-of-ly3214996-abemaciclib-and-m2-and-m20-metabolites-in-human-plasma-cerebrospinal-fluid-and-brain-tumor-by-lc-ms-ms/</loc>
		<lastmod>2023-03-27T14:44:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/blog/resource/a-phase-0-trigger-trial-of-cdk4-6-plus-erk1-2-inhibitors-in-recurrent-glioblastoma/</loc>
		<lastmod>2023-04-17T22:12:19+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->